Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ducressa vs Tobradex in Cataract Surgery
NCT03739528Phase 3Completed
- Sponsor
- NTC Pharma
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of levofloxacin + dexamethasone in post-operative ocular inflammation and ocular infection (2 arms), sponsored by NTC Pharma. Primary endpoint: Number of Participants Without Signs of Anterior Chamber Inflammation at Day 15. Started Sep 2018; status: completed.
02
Drugs
levofloxacin + dexamethasone
03
Conditions
post-operative ocular inflammationocular infection
Beyond the preview
Go deeper on NCT03739528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739528.